Biotech Funding
Selective Capital, Stronger Science: The Emerging Biotech Funding Model
David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-25-NI-04Jan 6, 2026
Global Growth
Beyond Borders: A Disciplined Approach to Successful Global Expansion
Eric B. Lev
Ampersand Capital Partners
PAO-08-25-CL-11Nov 4, 2025
CDMO Acquisition
TCP Analytical, Backed by Riverarch, Audax, Hillman, Lacy Diversified, and PPM America, Acquires Alconox, LLC
Alconox Inc.
PR-07-03-NI-13Jul 3, 2025
Investment
Orgenesis Secures up to USD 50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services
Orgenesis
PR-M11-22-05Nov 7, 2022
Private Equity
Supporting Growth for Middle-Market Companies
Jeffrey Marlough
Castleford Capital
PAO-02-22-R250-22Feb 27, 2022
The Future of Healthcare
How Does Dynamk Capital Envision the Future of the Pharma/Biopharma Industry?
Dynamk Capital
PAP-Q4-20-RT2-013Dec 9, 2020
Funding
Akoya Biosciences Raises $50 Million in New Financing
Akoya Biosciences
PR-M12-19-NI-010Dec 6, 2019
Executive Compensation
Executive Compensation: Essential Factor in Private Equity Transactions
Jeffrey Marlough
Castleford Capital
PAP-Q3-19-CL-007Oct 28, 2019
Attracting Investment
Preparing Middle-Market Firms to Attract Investment
Jeffrey Marlough
Castleford Capital
PAP-Q1-2019-CL-007Mar 12, 2019
Meet the Investor
Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider
David Q. Anderson
Ampersand Capital Partners
PAP-Q1-2019-CL-024Mar 12, 2019
R&D
Science Exchange Raises $28 million in Series C Funding
Guy Tiene
Nice Insight
PAO-M07-17-NI-021Jul 18, 2017
Investors May Look Smaller
Emilie Branch; Carrie Cao, Ph.D.; Cynthia A. Challener, Ph.D.; Nice Insight; Steve Kuehn
Pharma's Almanac
PAP-Q1-17-FA-008Mar 8, 2017
2017 Top 5 Industry Leader
Nice Insight
PAP-Q1-17-IL-001Mar 8, 2017